Market Overview:
The global ethinyl estradiol and levonorgestrel market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The hospital segment is expected to dominate the market in terms of revenue share during the forecast period. North America dominates the global ethinyl estradiol and levonorgestrel market, followed by Europe, Asia Pacific, Latin America and Middle East & Africa respectively.
Product Definition:
Ethinyl estradiol and levonorgestrel are two types of female hormones that are used in birth control pills. They work by preventing the ovaries from releasing eggs and also making it difficult for sperm to reach an egg.
0.02mg/0.1mg:
0.02mg/0.1mg (Also known as Ethinyl Estradiol and Levonorgestrel) is a synthetic estrogen used in birth control pills, skin patches, vaginal rings, and oral tablets. It is also sold under the name Plan B One-Step or Next Day Delivery in the U.S.
0.03mg/0.15mg:
0.03mg/0.15mg is used for oral contraceptive pills and it contains of ethinyl estradiol and levonorgestrel. The drug was approved by the FDA in September 2015, as a generic version of Plan B One-Step (one-step emergency contraception). It is sold under the brand name “Levonorgestrel-releasing Intrauterine System” by Teva Pharmaceutical Industries Ltd.
Application Insights:
The drug store application segment led the global ethinyl estradiol and levonorgestrel market in 2017. This is attributed to rising awareness about various benefits of oral contraceptives, such as lessening the risk of unplanned pregnancy and associated health problems. Moreover, growing demand for generic drugs is expected to fuel product demand in this segment over the forecast period.
The hospital application segment was valued at USD 2.5 million in 2017 owing to high usage rates of oral contraceptives by women seeking accidental or unwanted pregnancies due to extramarital affairs or mistreatment at hospitals or clinics. In addition, increasing awareness about these products among healthcare professionals is anticipated drive their demand over the forecast period (2018-2030).
Regional Analysis:
North America dominated the global ethinyl estradiol and levonorgestrel market in 2017. The presence of a large number of manufacturers coupled with high healthcare expenditure, awareness about contraception, and demand for oral contraceptives is some factors attributing to its largest share. In addition, the U.S., being one of the most developed countries in terms of healthcare delivery system has a wide base of population covered under private or government insurance programs which further increases access to contraceptive products thereby supporting regional growth.
Asia Pacific is expected to witness significant growth over the forecast period owing to increasing awareness about modern contraceptive methods among women as well as men; rising disposable income especially in developing countries such as India and China; growing urbanization resulting from rapid economic development along with an increase in fertility rate are some major factors responsible for its fastest CAGR during the forecast period.
Growth Factors:
- Increasing awareness about contraception and birth control methods
- Rising prevalence of sexually transmitted infections (STIs)
- Growing number of women in the workforce
- Increasing demand for long-term contraception methods
- Technological advancements in contraceptive products
Scope Of The Report
Report Attributes
Report Details
Report Title
Ethinyl Estradiol and Levonorgestrel Market Research Report
By Type
0.02mg/0.1mg, 0.03mg/0.15mg, 0.01mg/0.15mg, 0.02mg/0.09mg
By Application
Hospital, Drug Store
By Companies
Teva, Pfizer, Aurobindo Pharma, Laboratorios Leon Farma, Glenmark, Allergan, Avion Pharmaceuticals, LUPIN, Mayne Pharma, Novast, Teva, Amneal Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Ethinyl Estradiol and Levonorgestrel Market Report Segments:
The global Ethinyl Estradiol and Levonorgestrel market is segmented on the basis of:
Types
0.02mg/0.1mg, 0.03mg/0.15mg, 0.01mg/0.15mg, 0.02mg/0.09mg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drug Store
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Teva
- Pfizer
- Aurobindo Pharma
- Laboratorios Leon Farma
- Glenmark
- Allergan
- Avion Pharmaceuticals
- LUPIN
- Mayne Pharma
- Novast
- Teva
- Amneal Pharmaceuticals
Highlights of The Ethinyl Estradiol and Levonorgestrel Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 0.02mg/0.1mg
- 0.03mg/0.15mg
- 0.01mg/0.15mg
- 0.02mg/0.09mg
- By Application:
- Hospital
- Drug Store
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ethinyl Estradiol and Levonorgestrel Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ethinyl estradiol and levonorgestrel are synthetic hormones that are used to prevent pregnancy. Ethinyl estradiol is a female sex hormone and levonorgestrel is a male sex hormone.
Some of the major players in the ethinyl estradiol and levonorgestrel market are Teva, Pfizer, Aurobindo Pharma, Laboratorios Leon Farma, Glenmark, Allergan, Avion Pharmaceuticals, LUPIN, Mayne Pharma, Novast, Teva, Amneal Pharmaceuticals.
The ethinyl estradiol and levonorgestrel market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Ethinyl Estradiol and Levonorgestrel Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Ethinyl Estradiol and Levonorgestrel Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Ethinyl Estradiol and Levonorgestrel Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Ethinyl Estradiol and Levonorgestrel Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Ethinyl Estradiol and Levonorgestrel Market Size & Forecast, 2020-2028
4.5.1 Ethinyl Estradiol and Levonorgestrel Market Size and Y-o-Y Growth
4.5.2 Ethinyl Estradiol and Levonorgestrel Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 0.02mg/0.1mg
5.2.2 0.03mg/0.15mg
5.2.3 0.01mg/0.15mg
5.2.4 0.02mg/0.09mg
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drug Store
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Ethinyl Estradiol and Levonorgestrel Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Ethinyl Estradiol and Levonorgestrel Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 0.02mg/0.1mg
9.6.2 0.03mg/0.15mg
9.6.3 0.01mg/0.15mg
9.6.4 0.02mg/0.09mg
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drug Store
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 0.02mg/0.1mg
10.6.2 0.03mg/0.15mg
10.6.3 0.01mg/0.15mg
10.6.4 0.02mg/0.09mg
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drug Store
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 0.02mg/0.1mg
11.6.2 0.03mg/0.15mg
11.6.3 0.01mg/0.15mg
11.6.4 0.02mg/0.09mg
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drug Store
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 0.02mg/0.1mg
12.6.2 0.03mg/0.15mg
12.6.3 0.01mg/0.15mg
12.6.4 0.02mg/0.09mg
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drug Store
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 0.02mg/0.1mg
13.6.2 0.03mg/0.15mg
13.6.3 0.01mg/0.15mg
13.6.4 0.02mg/0.09mg
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drug Store
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Ethinyl Estradiol and Levonorgestrel Market: Competitive Dashboard
14.2 Global Ethinyl Estradiol and Levonorgestrel Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Teva
14.3.2 Pfizer
14.3.3 Aurobindo Pharma
14.3.4 Laboratorios Leon Farma
14.3.5 Glenmark
14.3.6 Allergan
14.3.7 Avion Pharmaceuticals
14.3.8 LUPIN
14.3.9 Mayne Pharma
14.3.10 Novast
14.3.11 Teva
14.3.12 Amneal Pharmaceuticals
